PharmaShots | Incisive News in 3 Shots

Subscribe Now

Intas Pharmaceuticals

Intas Pharmaceuticals Entered into a Collaboration and License Agreement with mAbxience for Etanercept Biosimilar to Treat Autoimmune Diseases

Intas Pharmaceuticals Entered into a Collaboration and License Agreement with mAbxience for Etanercept Biosimilar to Treat Autoimm...

December 20, 2023

Intas Pharmaceuticals Reports Real-World Study Results of Razumab (biosimilar, ranibizumab) for Polypoidal Choroidal Vasculopathy

Intas Pharmaceuticals Reports Real-World Study Results of Razumab (biosimilar, ranibizumab) for Polypoidal Choroidal Vasculopathy

April 15, 2023

Intas Pharmaceuticals Reports Retrospective Study Results of Razumab (biosimilar, ranibizumab) for the Treatment of Retinopathy of Prematurity

Intas Pharmaceuticals Reports Retrospective Study Results of Razumab (biosimilar, ranibizumab) for the Treatment of Retinopathy of...

April 8, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us